Hafnia’s TORM Stake Hits 18% After Another Major Stock Purchase
Hafnia TORM stake rises to 18.22% after a 4.5 million-share purchase, sending HAFN shares higher in Wednesday premarket trading.
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Hafnia TORM stake rises to 18.22% after a 4.5 million-share purchase, sending HAFN shares higher in Wednesday premarket trading.
U.S. stock futures fell as Novartis plunged 12.7% after pelacarsen’s Phase III trial missed its endpoint; other biotech stocks also declined.
Hafnia (NYSE:HAFN) reported quarterly earnings of $0.56 per share which beat the analyst consensus estimate of $0.53 by 5.66 percent. This is a 273.33 percent increase over earnings of $0.15 per share from the same
Kestra Medical fell 8.6% after missing earnings estimates despite beating sales forecasts; several other stocks also declined premarket.
TORM plc (the "Company" or "TORM") (NASDAQ:TRMD) (NASDAQ:TRMD) today announces the commencement of a secondary public offering of 9,000,000 (nine million) of the Company's Class A common shares by